Cellebrite DI Ltd.
General ticker "CLBT" information:
- Sector: Information Technology
- Industry: Software - Infrastructure
- Capitalization: $4.0B (TTM average)
Cellebrite DI Ltd. does not follow the US Stock Market performance with the rate: -5.1%.
Estimated limits based on current volatility of 2.4%: low 15.30$, high 16.06$
Factors to consider:
- Total employees count: 900 as of 2021
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [14.24$, 22.64$]
- 2026-12-31 to 2027-12-31 estimated range: [14.12$, 22.70$]
Financial Metrics affecting the CLBT estimates:
- Positive: with PPE of 41.3 at the end of fiscal year the price was neutral
- Positive: 7.57 < Operating profit margin, % of 13.98
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.70 > 6.02
- Positive: -0.03 < Operating cash flow per share per price, % of 3.60
- Positive: 42.57 < Shareholder equity ratio, % of 51.59 <= 64.23
- Negative: Industry operating cash flow per share per price (median), % of 2.15 <= 5.50
Short-term CLBT quotes
Long-term CLBT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $325.11MM | $401.20MM | $475.68MM |
| Operating Expenses | $291.87MM | $344.30MM | $409.19MM |
| Operating Income | $33.24MM | $56.91MM | $66.48MM |
| Non-Operating Income | $-108.80MM | $-332.89MM | $24.20MM |
| Interest Expense | $0.00MM | $349.76MM | $0.00MM |
| R&D Expense | $84.39MM | $98.42MM | $113.88MM |
| Income(Loss) | $-75.56MM | $-275.98MM | $90.68MM |
| Taxes | $5.54MM | $7.02MM | $12.35MM |
| Net Income(Loss)* | $-81.10MM | $-283.01MM | $78.33MM |
| Stockholders Equity | $34.21MM | $336.02MM | $484.32MM |
| Inventory | $9.94MM | $8.94MM | $7.60MM |
| Assets | $532.88MM | $690.57MM | $938.85MM |
| Operating Cash Flow | $102.06MM | $132.17MM | $168.96MM |
| Capital expenditure | $7.92MM | $10.61MM | $13.22MM |
| Investing Cash Flow | $-22.54MM | $-149.47MM | $-268.25MM |
| Financing Cash Flow | $21.77MM | $20.65MM | $29.64MM |
| Earnings Per Share** | $-0.43 | $-1.35 | $0.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.